PGC:NASDAQPeapack-Gladstone Financial Corporation Analysis
Data as of 2026-04-24 - not real-time
$39.44
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Peapack‑Gladstone Financial (PGC) is trading at $39.44, comfortably above its 20‑day SMA ($37.90) and 50‑day SMA ($35.55), signaling a sustained bullish momentum. The RSI sits at 64, indicating strength without being overbought, while the MACD remains bullish with a positive histogram, and volume is on an upward trend, all reinforcing the current upside bias. Revenue growth of 25.5% and an operating margin of 28% illustrate robust earnings expansion, and the forward PE of 8.43 suggests the stock is priced attractively relative to its earnings outlook. Valuation metrics are supportive: a trailing PE of 15.97 is below the industry average of 17.34, the price‑to‑book ratio of 1.04 hovers near parity, and the target price of $40.5 offers a modest upside of roughly 2.7% from today’s level. Dividend sustainability appears solid with a low payout ratio of 8% and a cash position that more than doubles the debt balance, while the beta of ~1.03 and 30‑day volatility of 26% reflect typical bank‑sector risk without extreme price swings.
The recent earnings call highlighted an 18‑bp expansion in net interest margin to 3.26% and a strategic push for 1% ROA and 10% return on capital, underscoring management’s focus on profitability and disciplined growth. With a market cap under $1 billion, increasing trading volume, and an “Extreme Greed” sentiment reading, the stock sits at a favorable risk‑reward juncture, though upside is limited by its proximity to the $40.41 resistance level.
The recent earnings call highlighted an 18‑bp expansion in net interest margin to 3.26% and a strategic push for 1% ROA and 10% return on capital, underscoring management’s focus on profitability and disciplined growth. With a market cap under $1 billion, increasing trading volume, and an “Extreme Greed” sentiment reading, the stock sits at a favorable risk‑reward juncture, though upside is limited by its proximity to the $40.41 resistance level.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near short‑term resistance at $40.41
- Bullish technical indicators (MACD, SMA crossover)
- Limited near‑term upside potential
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Attractive forward PE of 8.43
- Strong revenue growth and expanding net interest margin
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable earnings profile and solid balance sheet
- Moderate beta and volatility consistent with regional banks
- Management’s roadmap to improve ROA and return on capital
Key Metrics & Analysis
Financial Health
Revenue Growth25.50%
Profit Margin16.02%
P/E Ratio16.0
ROE6.64%
ROA0.59%
P/B Ratio1.0
Industry P/E17.3
Technical Analysis
TrendBullish
RSI64.1
Support$34.40
Resistance$40.41
MA 20$37.90
MA 50$35.55
MA 200$29.98
MACDBullish
VolumeIncreasing
Fear & Greed Index88.02
Valuation
Target Price$40.50
Upside/Downside2.69%
GradeUndervalued
TypeBlend
Dividend Yield0.50%
Risk Assessment
Beta1.04
Volatility26.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.